Five biotech and pharma stocks to watch

FiercePharma's sister publication FierceBiotech asked prominent market analysts to weigh in on major biopharma milestones on the near horizon. So Dr. Simos Simeonidis, the senior biotech analyst for Rodman & Renshaw, scanned the radar for key upcoming events. He focuses on five biotech and pharma companies at important crossroads in their development. Their success or failure at this juncture will have a big impact on their future. Article

Suggested Articles

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.